已核实 DOI PubMed 相关产品: 33

Ultrasensitive ECL immunoassay for CA15-3 via self-enhanced L012-loaded ZnNi-MOF as an emitter and CeO2-Pt as a co-reaction accelerator

Journal 2024 · IF 5.6 · 发表于 2024 年 10 月 28 日
作者: Chen Cui,Naxin Liu,Qiurui Nian,Yuntao Xia,Liuchuang Zhao,Leqian Hu,Hongjuan Bai,Dechen Jiang
阅读全文 在 PubMed 查看

摘要

Improvement in the sensitivity and accuracy of ECL-based biosensors, to a great extent, depends on the fabrication of high-performance electrochemiluminescence (ECL) sensors. Herein, polyethyleneimine (PEI)-grafted bimetallic ZnNi metal-organic framework (ZnNi-MOF/PEI) nanospheres were synthesized to prepare a L012-based ECL immunosensor for detecting carbohydrate antigen 15-3 (CA15-3). The introduced PEI was utilized not only as a bridging element for L012 luminophore and detection antibody (Ab 2 ) immobilization but also as a co-reactant for generating the self-enhanced ZnNi-MOF/PEI-L012@Ab 2 ECL signal probe. Furthermore, Pt nanoparticle-functionalized CeO 2 nanorods (CeO 2 -Pt) featuring high-efficiency electrocatalytic properties, as a co-reaction accelerator, could catalyze H 2 O 2 to generate abundant reactive oxygen species (ROS), further augmenting the ECL signal of ZnNi-MOF/PEI-L012@Ab 2 . In the presence of CA15-3 antigen, the capture antibody (Ab 1 )-conjugated CeO 2 -Pt complex (CeO 2 -Pt@Ab 1 ) and ZnNi-MOF/PEI-L012@Ab 2 would get closer to each other, with the formation of a "signal-on" sandwich-type ECL immunosensor. The ZnNi-MOF-assisted ECL biosensor achieved a detection limit of down to 5.75✕10 -5 U mL -1 . This work shows distinguished potential for measuring low levels of biomarkers that may help in the clinical diagnosis of breast cancer.

本研究中使用的阿拉丁产品

33 款产品在本文中被引用